TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11979239

Group type: EXPERIMENTAL
Intervention: Large-volume epinephrine injection (13-20 mL)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Small-volume epinephrine injection (5-10 mL)
Number of subjects: 156
Study: 29888938

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion for thought insertion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion for alien control
Number of subjects: 60

Group type: COMPARATOR
Intervention: Random responding suggestion
Number of subjects: 60
Study: 27112637

Group type: EXPERIMENTAL
Intervention: Haloperidol (3mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22032553

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) - Health Dialog's Looking Ahead: choices for medical care when you're seriously ill (booklet and DVD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard Palliative Care (PC) consultation
Number of subjects: 51
Study: 21828036

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F) 100/10 μg b.i.d.
Number of subjects: 746

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 746

Group type: COMPARATOR
Intervention: Formoterol (F) 10 μg
Number of subjects: 746

Group type: COMPARATOR
Intervention: Mometasone furoate (MF) 100 μg
Number of subjects: 746
Study: 20189089

Group type: EXPERIMENTAL
Intervention: Audit feedback plus site-specific interventions (n=6)
Number of subjects: 3311

Group type: COMPARATOR
Intervention: Audit feedback alone (n=7)
Number of subjects: 3311
Study: 18536598

Group type: EXPERIMENTAL
Intervention: 1 mg IVTA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2 mg IVTA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4 mg IVTA
Number of subjects: 45
Study: 15815904

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing of the tibia with traction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intramedullary nailing of the tibia without traction
Number of subjects: 30
Study: 12448658

Group type: EXPERIMENTAL
Intervention: Arm A: 25 microg/m2 bryostatin-1 given as a 24 hour continuous infusion weekly
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Arm B: 120 microg/m2 bryostatin-1 given as a 72 hour continuous infusion every 2 weeks
Number of subjects: 34
Study: 10503055

Group type: EXPERIMENTAL
Intervention: Lifting a box of unknown weight at 4.3 lifts/min
Number of subjects: 15
Study: 7852514

Group type: EXPERIMENTAL
Intervention: Oral pamidronate, 150 mg/day for at least 5 years
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral pamidronate
Number of subjects: 20
Study: 1672494

Group type: EXPERIMENTAL
Intervention: Cetirizine 5 mg
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 419

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 419
Study: 7039328

Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Timolol maleate and Acetazolamide (combination)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31877119

Group type: EXPERIMENTAL
Intervention: 10-week resistance training (RT) program (2 d·wk in the first 5 weeks; 3 d·wk in the last 5 weeks)
Number of subjects: 25
Study: 31095946

Group type: EXPERIMENTAL
Intervention: LOW muscle glycogen (1.5 g/kg carbohydrate, 3.0 g/kg fat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: AD muscle glycogen (6.0 g/kg carbohydrate, 1.0 g/kg fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: LOW muscle glycogen
Number of subjects: 12

Group type: COMPARATOR
Intervention: AD muscle glycogen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both LOW and AD muscle glycogen
Number of subjects: 12
Study: 28351168

Group type: EXPERIMENTAL
Intervention: Core stability exercises for 15 minutes/day in addition to conventional physiotherapy (5 days/week for 5 weeks)
Number of subjects: 79
Study: 25829456

Group type: EXPERIMENTAL
Intervention: TIMA (Texas Implementation of Medication Algorithm)
Number of subjects: 61

Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 61
Study: 25124938

Group type: EXPERIMENTAL
Intervention: Non-episiotomy protocol (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective episiotomy (control group)
Number of subjects: 0
Study: 22623749

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention for parents including printed resources and four 30-min telephone calls
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control group received generic printed nutrition information
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention for parents
Number of subjects: 394
Study: 20849715

Group type: EXPERIMENTAL
Intervention: Probiotics (0.25 g, twice daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 17620777

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) + standard of care (RICE)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo (PL) + standard of care (RICE)
Number of subjects: 158
Study: 15887025

Group type: EXPERIMENTAL
Intervention: 2-km trial at the 10-km race speed (v2km)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400-m trials at increasing speeds (v1, v2, v3)
Number of subjects: 10
Study: 11251424

Group type: EXPERIMENTAL
Intervention: Sevoflurane with nitrous oxide (FI = 0.63 +/- 2.5)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sevoflurane alone
Number of subjects: 45
Study: 9855027

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1650

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1650
Study: 8110536

Group type: EXPERIMENTAL
Intervention: Retrobulbar block alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anaesthesia alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: General anaesthesia combined with retrobulbar block given after induction
Number of subjects: 30
Study: 2848432

Group type: EXPERIMENTAL
Intervention: RIT 4237 live attenuated bovine rotavirus vaccine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 31097514

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 µg
Number of subjects: 1691

Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 µg
Number of subjects: 1691

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1691
Study: 30650265

Group type: EXPERIMENTAL
Intervention: Jinchuang Ointment (JO)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Traditional Chinese herbal medicine ointment
Number of subjects: 306

Group type: COMPARATOR
Intervention: MepilexAg
Number of subjects: 306
Study: 25840297

Group type: EXPERIMENTAL
Intervention: Topical neomycin sulfate/ polymyxin-B sulfate (3500 IU/mL neomycin sulfate/6000 IU/mL polymyxin-B sulfate) applied 1 hour before surgery (Group 1)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Topical neomycin sulfate/ polymyxin-B sulfate (3500 IU/mL neomycin sulfate/6000 IU/mL polymyxin-B sulfate) applied 1 day before surgery (Group 2)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Povidone-iodine 1.0% irrigation
Number of subjects: 133
Study: 23915067

Group type: EXPERIMENTAL
Intervention: Smoking cessation programme with a smartphone app for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21830966

Group type: EXPERIMENTAL
Intervention: t‐PA and DNase
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: DNase
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 210
Study: 19836707

Group type: COMPARATOR
Intervention: Formocresol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide/iodoform
Number of subjects: 0
Study: 16901427

Group type: COMPARATOR
Intervention: Tibialis anterior contraction
Number of subjects: 0
Study: 15023753

Group type: EXPERIMENTAL
Intervention: Sentinel node (SN) resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional axillary dissection
Number of subjects: 0
Study: 10634336

Group type: EXPERIMENTAL
Intervention: Triple drug (zidovudine, lamivudine, and indinavir)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zidovudine-indinavir
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (sustained viral suppression)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Triple drug cases
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine arm
Number of subjects: 58
Study: 9102023

Group type: EXPERIMENTAL
Intervention: Modified K‐wire technique of Kapandjii
Number of subjects: 0

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 0
Study: 1392755

Group type: EXPERIMENTAL
Intervention: Health visitor intervention including assessment and correction of nutritional deficiencies, medical conditions, environmental hazards, and fitness improvement; duration: 4 years.
Number of subjects: 674

Group type: COMPARATOR
Intervention: Control group (no health visitor intervention).
Number of subjects: 674
Study: 29809091

Group type: EXPERIMENTAL
Intervention: School-based health education model based on protection motivation theory (PMT)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 231
Study: 31481074

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 28434662

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (CBA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB) for restenotic lesions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (CBA) for restenotic lesions
Number of subjects: 40
Study: 25001888

Group type: EXPERIMENTAL
Intervention: CBOP/BEP (carboplatin, bleomycin, vincristine, cisplatin/BEP); 2×CBOP, 2×BO, and 3×BEP (bleomycin 15,000 IU)
Number of subjects: 89

Group type: COMPARATOR
Intervention: BEP (bleomycin 30,000 IU); composed of four cycles over 12 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: CBOP/BEP
Number of subjects: 89

Group type: COMPARATOR
Intervention: BEP
Number of subjects: 89
Study: 24854297

Group type: EXPERIMENTAL
Intervention: Development of pressure ulcer (PU) grade ≥ II
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Overall hospital mortality
Number of subjects: 563
Study: 23116381

Group type: EXPERIMENTAL
Intervention: Work‐Ordered Day program participation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (Program of Assertive Community Treatment team)
Number of subjects: 43
Study: 19950739

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 10 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ondansetron 50 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Midazolam 50 microg/kg plus Dexamethasone 0.5 mg/kg
Number of subjects: 100
Study: 17307170

Group type: EXPERIMENTAL
Intervention: Asoprisnil 5 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Asoprisnil 10 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Asoprisnil 25 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 15193944

Group type: EXPERIMENTAL
Intervention: Manipulation of an object with the right hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation of an object with the left hand
Number of subjects: 0
Study: 12681347

Group type: EXPERIMENTAL
Intervention: Attention focused on pseudowords
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Attention focused on vowel sounds
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Attention focused on words
Number of subjects: 13

Group type: COMPARATOR
Intervention: Passive listening
Number of subjects: 13
Study: 10331682

Group type: EXPERIMENTAL
Intervention: Left-sided amobarbital injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Right-sided amobarbital injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left hemisphere injection (second)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left hemisphere injection
Number of subjects: 0
Study: 8768841

Group type: EXPERIMENTAL
Intervention: Oral conjugated estrogen (1.25 mg daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (100 micrograms/day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GHRH administration after oral estrogens
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GHRH administration after transdermal estrogens
Number of subjects: 16

Group type: COMPARATOR
Intervention: GHRH-stimulated GH levels
Number of subjects: 16
Study: 1847128

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX) with total doses of 69.6 Gy
Number of subjects: 516

Group type: COMPARATOR
Intervention: Standard fractionation (STD) with 60 Gy in 30 fractions in 6 weeks
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: RTOG Stage III patients
Number of subjects: 516
Study: 7039841

Group type: EXPERIMENTAL
Intervention: Single daily dose of methyldopa
Number of subjects: 27

Group type: COMPARATOR
Intervention: Multiple daily dose of methyldopa
Number of subjects: 27
Study: 3892270

Group type: EXPERIMENTAL
Intervention: Biosynthetic human insulin (BHI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 20
Study: 29671955

Group type: EXPERIMENTAL
Intervention: Dietitian-delivered health behavior intervention
Number of subjects: 307
Study: 27589542

Group type: EXPERIMENTAL
Intervention: Oral sildenafil and inhaled nitric oxide (iNO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo and inhaled nitric oxide (iNO)
Number of subjects: 24
Study: 25355268

Group type: EXPERIMENTAL
Intervention: Community nursing intervention (health knowledge lecture and individual community nursing intervention)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine management (control group)
Number of subjects: 120
Study: 22261815

Group type: EXPERIMENTAL
Intervention: Knee icing for 30 minutes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Elbow icing for 30 minutes (Control)
Number of subjects: 20
Study: 20056373

Group type: EXPERIMENTAL
Intervention: Breast pumping 0.6h after drinking a 0.4g/kg dose of alcohol (pumped after group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breast pumping 1h before drinking a 0.4g/kg dose of alcohol (pumped before group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fasted condition
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fed condition
Number of subjects: 12
Study: 19216446

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (bolus 50 mg/kg and 0.5 g/h)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16020773

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 20

Group type: COMPARATOR
Intervention: No statins
Number of subjects: 20
Study: 12848839

Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) project interventions
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Challenges faced by the partnership
Number of subjects: 23
Study: 10855852

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy consisting of 6 cycles of CMF for patients with high TLI tumors
Number of subjects: 11

Group type: COMPARATOR
Intervention: Local-regional therapy alone for patients with low TLI tumors
Number of subjects: 11
Study: 8640621

Group type: EXPERIMENTAL
Intervention: Preoperative tutorial
Number of subjects: 8
Study: 1523878

Group type: EXPERIMENTAL
Intervention: Wy‐Ad7HZ6‐1
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Adenovirus type 7 vaccine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6568095

Group type: EXPERIMENTAL
Intervention: Closed-loop method
Number of subjects: 45

Group type: COMPARATOR
Intervention: Capped-syringe method
Number of subjects: 45

Group type: COMPARATOR
Intervention: Double-bag method
Number of subjects: 45
Study: 30871596

Group type: EXPERIMENTAL
Intervention: Individual CRAFT
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Group CRAFT
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Self-help CRAFT
Number of subjects: 405

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 405
Study: 29964043

Group type: EXPERIMENTAL
Intervention: Methotrexate (25 mg/wk)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 26723472

Group type: EXPERIMENTAL
Intervention: Conversation-based intervention (4 sessions over 2 weeks)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Conversation-based intervention
Number of subjects: 101
Study: 24650819

Group type: EXPERIMENTAL
Intervention: Alcohol (target dose: .08 mg/kg)
Number of subjects: 152

Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 152
Study: 22770549

Group type: EXPERIMENTAL
Intervention: Amiodarone 300 mg
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg/kg
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 20400766

Group type: EXPERIMENTAL
Intervention: Carto-Merge
Number of subjects: 299

Group type: COMPARATOR
Intervention: Carto-XP
Number of subjects: 299
Study: 18083472

Group type: EXPERIMENTAL
Intervention: Sciatic psoas compartment (SPC) block
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sciatic femoral 3‐in‐1 (SF 3‐in‐1) block
Number of subjects: 36
Study: 16236940

Group type: EXPERIMENTAL
Intervention: Muscle-sparing thoracotomy (MT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Posterolateral thoracotomy (PT)
Number of subjects: 120
Study: 12004273

Group type: EXPERIMENTAL
Intervention: recombinant human IL-12 (rhIL-12) dosed twice weekly for 4 weeks at < or = 100 ng/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 9585709

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (running)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clomipramine (112.5 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 8593380

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU orally at 6-month intervals)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 269
Study: 2582711

Group type: EXPERIMENTAL
Intervention: Ranitidine 50 mg every 8 hours
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg every 12 hours
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ranitidine 6.25 mg/hr continuous infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ranitidine 10 mg/hr continuous infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 186417

Group type: COMPARATOR
Intervention: Immunotherapy with Pasteur strain BCG, either alone or combined with allogeneic tumor cells.
Number of subjects: 107

Group type: COMPARATOR
Intervention: No immunotherapy (control group).
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Immunotherapy groups (general).
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Immunotherapy groups (large-cell anaplastic carcinoma).
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Immunotherapy groups (small-cell anaplastic carcinoma).
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Leukocyte migration inhibition assays with tumor-associated antigens.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 3 M KCl extract of pleural effusion cells from a patient with pulmonary adenocarcinoma.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Mixed lymphocyte/tumor interaction to tumor-associated antigens.
Number of subjects: 107
Study: 31943189

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Emotion Regulation (ER)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Usual class control
Number of subjects: 295
Study: 30902793

Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: QMix
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 100

Group type: COMPARATOR
Intervention: MTA Fillapex
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study: 28505987

Group type: EXPERIMENTAL
Intervention: 2mA anodal tDCS (a-tDCS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1mA anodal tDCS (a-tDCS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham anodal tDCS (a-tDCS)
Number of subjects: 11
Study: 25404229

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 25012726

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg IV before chemotherapy, followed by 24 mg continuous infusion and 8 mg IV once daily for 2 days post-chemotherapy)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: ABCB1 3435CC genotype
Number of subjects: 215
Study: 21816128

Group type: EXPERIMENTAL
Intervention: Increased left atrial dimension (LAD)
Number of subjects: 286
Study: 20095330

Group type: EXPERIMENTAL
Intervention: VitB2 5 mg, VitC 200 mg, GPC capsule 50 mg, once every other day and VitA capsules 25,000 units weekly during sea-voyage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 50
Study: 17718872

Group type: EXPERIMENTAL
Intervention: Doula support (n = 229)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard care (n = 265)
Number of subjects: 600
Study: 15479324

Group type: EXPERIMENTAL
Intervention: New pulmonary artery catheter
Number of subjects: 25

Group type: COMPARATOR
Intervention: Transoesophageal echocardiography
Number of subjects: 25